ANILA ABRAHAM: Open Payments
NPI 1194204404 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 23 payments from 7 companies in 2025. Trend: 2023 $50 · 2024 $902 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $199 |
| ABBVIE INC. | 10 | $153 |
| Otsuka America Pharmaceutical, Inc. | 3 | $138 |
| Axsome Therapeutics, Inc. | 1 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
Products named: FANAPT, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, COBENFY, UZEDY, ABILIFY ASIMTUFII.
Industry payments across IN — which companies pay providers there.
